-
Mashup Score: 6Cancer Podcast: Cancer Straight Talk from MSK - 11 month(s) ago
Cancer Straight Talk from MSK is a podcast about cancer that brings together patients and experts, to have straightforward evidence-based conversations. Memorial Sloan Kettering’s Dr. Diane Reidy-Lagunes hosts this cancer podcast with a mission to educate and empower cancer patients and their family members.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2FDA Approves Teclistamab, a Promising New Drug for Multiple Myeloma Targeting BCMA and CD3 Proteins - 11 month(s) ago
Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Learn how researchers engineered CAR T cells to work better by using a mutation in a gene called c-KIT that drives cancer cell growth.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 15MSK-Led Research Finds Unexpected Link Between Chromosomal Instability and Epigenetic Alterations - 11 month(s) ago
MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Targeted Therapy Delays Growth for IDH-Mutant Glioma - 11 month(s) ago
Neuro-oncologist Ingo Mellinghoff, MD, FACP discusses how his research has led to a new targeted therapy for IDH-mutant glioma – and details how this may mark a paradigm shift in therapeutic options for patients with brain tumors.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1MSK Research Roundup at ASCO 2023: Advances in Glioma, Rectal Cancer, Lung Cancer, Biliary Tract Cancer, and More - 11 month(s) ago
Memorial Sloan Kettering Cancer Center (MSK) researchers presented breakthrough advances in new treatment approaches for several cancer indications at the 2023 ASCO Annual Meeting held June 2 to 6, 2023. Highlights of practice-changing study results in glioma, rectal cancer, non-small cell lung cancer, biliary tract cancer, and more were as follows:
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
MSK investigators are leading research focused on understanding how hereditary DNA mutations affect cancer development and therapy, and how to best treat people who carry these inherited risks in their genes.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Rectal Cancer Treatment Without Radiation: A New Option - 11 month(s) ago
Learn about a clinical trial at Memorial Sloan Kettering that gives people with rectal cancer a new option to be treated without radiation. The research shows that a well-known chemotherapy regimen used alone can be just as effective as chemotherapy given with radiation before surgery. The new method may reduce side effects associated with radiation such as loss of fertility and impaired bladder…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Ovarian Cancer - 11 month(s) ago
Find out how cancer can develop in a woman’s ovaries, fallopian tubes, and peritoneum. Learn how we’re improving the outlook for people ovarian cancer.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
A new experimental drug could be an effective treatment for some people with low-grade glioma.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
On the latest episode of the Cancer Straight Talk from MSK podcast, we dive deep into the side effects of treatment: what they are, why they happen, and how to cope. Listen here: https://t.co/QghONpCqXF https://t.co/hX3Me0vc0a